Not recruitingISRCTN27750123
Efficacy and tolerability of ziprasidone versus clozapine in the treatment of dually diagnosed (DD-) patients with schizophrenia and Addiction: a randomised study
Research studyGermany
Understand this study
Who could participate?
This study is for people with schizophrenia. Other eligibility criteria apply.
- Listed locations
- Germany
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University of Cologne (Germany)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- ISRCTN27750123
- Official title
Show the full official title
Efficacy and tolerability of ziprasidone versus clozapine in the treatment of dually diagnosed (DD-) patients with schizophrenia and Addiction: a randomised study
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Germany
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cologne (Germany), a university.
Who can participate?
This study is for people with schizophrenia. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
